Introduction
Colorectal cancer (CRC) is the third most common cancer and a leading cause of cancer-related mortality worldwide. 1, 2 Over the past several decades, the outcomes
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li et al of CRC patients have improved significantly owing to advanced surgical techniques and novel adjuvant chemotherapy regimens, but the 5-year survival rate remains ~60%. 3, 4 In clinical practice, a variety of approaches have been tried to systematically manage CRC to improve poor outcomes. Tumor-node-metastasis (TNM) staging is the most significant risk factor for CRC, 5 and it is recommended that stage III and high-risk stage II patients undergo adjuvant chemotherapy. 6 However, the prognosis and chemotherapeutic sensitivity of CRC in patients with the same TNM stage vary distinctly. TNM staging based on clinicopathological characteristics, such as tumor location 7 and perineural invasion (PNI), 8 has been widely investigated. However, to date, the optimal prognostic factor for CRC has not been discovered and further investigation is warranted. Therefore, additional sensitive predictive factors that can be easily acquired are needed to better evaluate the prognosis and response to chemotherapy of CRC and used as supplementary factors for TNM staging.
Macroscopic morphological features are common medical parameters that can easily be obtained from medical records and help classify CRC in China. Tumors are commonly classified into three morphological subtypes (expansive, infiltrative and ulcerative subtypes) according to gross observations based on the Chinese Standard for the Diagnosis and Treatment of Colorectal Cancer (2010), 9 and the colonoscopic findings of these subtypes are shown in Figure 1 .
Extensive studies have investigated the relationship between histological findings and clinical outcomes of CRC, but no consensus has been reached on the prognostic and predictive value of macroscopic growth patterns in CRC. 10 Previous studies have shown that the gross tumor configuration is a factor with no prognostic significance. 11, 12 However, accumulating evidence has demonstrated that CRC is characterized differently based on macroscopic morphological features, including biological behaviors, genetic features and prognosis. 13, 14 Yang et al found that in terms of prognosis, gross tumor type was correlated with disease-free interval. 15 Chen et al divided CRC into two morphologies (massive and ulcerative/infiltrative morphologies) and found that the ulcerative/infiltrative morphology was an independent risk factor for apical node metastasis and thus was correlated with poor prognosis. 16 Chian et al also divided CRC into two major groups (polypoid and ulcerative CRC) which displayed different genetic alterations and clinicopathological features. 17 However, they excluded the infiltrative subtype or combined it with the ulcerative subtype. Few studies have compared the clinical survival and response to chemotherapy between the infiltrative subtype and other subtypes, which should not be neglected.
Thus, in the present study, expansive, infiltrative and ulcerative growth patterns were evaluated as distinct subtypes, and we compared the clinical, pathological and molecular features among them to investigate whether different macroscopic growth patterns were associated with the prognosis. Furthermore, for stage III CRC patients, we compared the prognosis of the chemotherapy group and the nonchemotherapy group with different macroscopic growth patterns to evaluate the predictive effect of macroscopic growth patterns for chemotherapeutic efficacy.
Patients and methods Patients
A total of 4,080 qualified CRC patients who were treated at Shandong Provincial Hospital affiliated to Shandong University between March 2000 and July 2016 were retrospectively recruited. The inclusion criteria were as follows: 1) patients with pathologically confirmed carcinoma of the colon and rectum; 2) patients who underwent curative surgical resection; 3) patients who were 18-90 years old at the time of diagnosis and 4) patients with stage I-III CRC. The exclusion criteria were as follows: 1) patients with two or more asynchronously or synchronously primary tumors; 2) patients with synchronous distant metastases; 3) patients without data regarding macroscopic growth pattern or 4) patients who 
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Data collection
The intact data, including clinicopathological features and demographic characteristics, were collected from the hospital database by trained staff. The data collection procedures were controlled for quality, and the data collected were standardized. The following parameters were recorded: gender, age at diagnosis, primary tumor location, tumor differentiation, TNM stage, histological subtype, macroscopic growth pattern, presence of venous invasion, presence of PNI, presence of tumor deposits and chemotherapeutic treatment.
ethical approval and informed consent
The study protocol was approved by the Ethics Committee of Shandong Provincial Hospital affiliated to Shandong University. Written informed consent was obtained, and all the methods used were performed in accordance with the relevant guidelines and regulations from the committee.
Follow-up
Follow-up data were collected from the tumor registry database and the total death database of the Shandong Center for Disease Control and Prevention by the School of Public Health, Shandong University. The overall survival (OS), cancer-specific survival (CSS) and disease-free survival (DFS) were selected as primary endpoints. The OS was defined as the time from initial surgical treatment to death due to any cause. The CSS was calculated from the date of surgery to the date of CRC-specific death. Deaths attributed to other causes were censored. The DFS was defined as the period from surgical resection to first recurrence or metastasis or end of life. Patients who were still alive at the last follow-up were censored. The median duration of follow-up for all patients was 39.11 months (range 0.03-207.5 months).
statistical analysis
Continuous variables are reported as the median and range, and categorical variables are presented as frequencies and percentages unless otherwise stated. The chi-square test (c²) test or the Fisher's exact test was utilized to compare differences in the distributions and proportions of the demographic and clinicopathological variables by macroscopic growth patterns. Survival curves of OS, CSS and DFS were generated by the Kaplan-Meier method and compared by the log-rank test. Multicollinearity diagnosis was performed before constructing the multivariate regression model. The association between macroscopic growth patterns and clinical outcomes (OS, CSS and DFS) was evaluated, and the corresponding HRs and 95% CIs for prognostic factors were obtained from the univariate and multivariate Cox proportional hazard models. The effect of macroscopic growth patterns on OS, CSS and DFS was also assessed in subset analyses that were stratified by TNM stages and several other baseline variables. All statistical analyses were performed with SPSS software version 22.0 (SPSS Inc, Chicago, IL, USA). Statistical significance was set at a two-sided P-value<0.05.
Results
Patient characteristics
Patients' baseline demographic and clinicopathological parameters are summarized in Figure 2A -C). In the stage I subanalysis, there were no significantly differences among the three subtypes (P=0.697, 0.768 and 0.759, respectively; Figure 2D -F). In the stage II subanalysis, the infiltrative subtype had the worst DFS (P=0.033; Figure 2I ), but similar OS and CSS (P=0.682 and 0.382, respectively; Figure 2G and H). In the stage III subanalysis, the infiltrative subtype had the worst OS, CSS and DFS (P=0.008, P=0.003 and P<0.001, respectively; Figure 2J -L).
The 5-year survival rates of the expansive, infiltrative and ulcerative subtypes were 72%, 56% and 67%, respectively. For stage I patients, the 5-year survival rates of the expansive and ulcerative subtypes were 86% and 83%, respectively. For stage II patients, the 5-year survival rates of the expansive, infiltrative and ulcerative subtypes were 71%, 89% and 77%, respectively. For stage III patients, the 5-year survival rates of the expansive, infiltrative and ulcerative subtypes were 58%, 44% and 55%, respectively.
Univariate and multivariate Cox analyses by growth pattern and tumor stage
For all stages, the univariate Cox proportional hazard model of OS revealed an increased risk of mortality for the infiltrative 
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subset analyses
Multivariate Cox proportional hazard regression analyses were performed with various subsets. In the subset analyses of OS (Figure 4 ), CSS ( Figure 5 ) and DFS (Figure 6 ), the infiltrative subtype was associated with worse prognosis than the ulcerative subtype for male patients, younger patients, patients with moderately differentiated cancer, patients with the nonmucinous subtype, patients with LCC or RECC, patients who were negative for venous invasion or PNI and patients without tumor deposits. By contrast, the expansive subtype was associated with better OS, CSS and DFS than the ulcerative subtype for patients with the nonmucinous subtype, patients with RECC, patients who were negative for venous invasion or PNI and patients without tumor deposits.
Discussion
The TNM staging system, which includes assessments of the local tumor extent, the status of regional lymph nodes and the presence of metastasis, is the gold standard in clinical practice. 18 However, many patients with a lower TNM stage have a worse prognosis than those with a higher TNM stage, and not all patients benefit from chemotherapy. Thus, complementary predictive factors need to be identified to better evaluate the prognosis and response to chemotherapy of CRC.
In the past several decades, studies have focused on prognostic markers for CRC. However, controversy remains regarding the prognostic value of the macroscopic growth pattern. Most previous studies have excluded the infiltrative subtype or combined it with the ulcerative subtype. However, we thought there might be some differences in the mortality, recurrence or metastasis between the infiltrative subtype and other subtypes, which should not be neglected.
In the present study, all three macroscopic growth patterns were evaluated as distinct subtypes, and their demographic and clinicopathological features were compared. Our stagebased analysis revealed that compared with the infiltrative and ulcerative subtypes, the expansive subtype was associated with higher frequencies of favorable characteristics, including well-differentiation, lower TNM stage, less lymph node invasion, less venous invasion or PNI and absent tumor deposits. However, compared with the expansive and ulcerative subtypes, the infiltrative subtype consisted of a greater proportion of the mucinous subtype, indicating that the expansive subtype may have a better prognosis while the infiltrative subtype may have a worse prognosis. These findings may be attributed to the different biological behaviors of different morphological subtypes influencing tumorigenesis.
In addition, the Kaplan-Meier curves and univariate analyses of OS, CSS and DFS showed that the macroscopic growth pattern was a significant prognostic factor for CRC patients. Similar to previous studies, 14 the ulcerative subtype is in an intermediate position between the best of the expansive subtype and the worst of the infiltrative subtype with regard to OS, CSS and DFS. However, in the subset analysis based on 
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Prognostic value of the macroscopic growth pattern in colorectal cancer the TNM stage, significant differences were observed between the infiltrative subtype and the ulcerative subtype for stage III patients in terms of OS, CSS and DFS and for stage II patients in terms of DFS. The fact that stage I CRC patients usually have good prognosis may account for the results.
Furthermore, after controlling for age; tumor differentiation; histological subtype and the presence of PNI, venous invasion and tumor deposits for OS and CSS, we observed significant differences in the OS and CSS between the three CRC subtypes. After controlling for gender; differentiation; histological subtype and the presence of venous invasion, PNI and tumor deposits for DFS, significant differences in the DFS were also observed. However, in the subset analyses based on the TNM stage, patients with the infiltrative subtype had the worst DFS in stage II patients and the worst OS, CSS and DFS in stage III patients than other subtypes. In the subset analyses based on other clinicopathological factors, the infiltrative subtype was an independent prognostic factor in various subgroups, such as patients with the nonmucinous subtype, patients with RECC, patients who were negative for venous invasion or PNI and patients without tumor deposits, indicating that the macroscopic growth pattern may be a strong candidate for predicting the prognosis of CRC.
As not all patients benefit from adjuvant chemotherapy, it is important to find a sensitive predictive factor for chemotherapeutic efficacy to guide treatment strategies. Thus, we further compared the OS, CSS and DFS among the three macroscopic growth patterns using Kaplan-Meier CRC prognosis and chemotherapeutic efficacy by combining macroscopic morphological features with other clinicopathological features in a relatively large Chinese cohort. However, there are several potential limitations of the present study that should be acknowledged. First, this study is a single-center study and additional multicenter studies are needed for further validation. Second, the present study is retrospective, and selection bias could not be completely avoided. Third, the patients recruited in this study are Chinese, and the application of the findings to other ethnic groups remains unclarified. Fourth, patients with tumors with an ambiguous appearance and stage IV CRC were excluded; therefore, we cannot give further recommendations for these patients. Further investigation should be conducted to examine whether 
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Conclusion
The macroscopic morphological subtype can be easily determined from medical records, and CRC with different growth patterns exhibits distinct clinical behaviors. The macroscopic growth pattern was an independent prognostic factor among stage I-III CRC patients in China. In addition, the infiltrative subtype had the worst DFS for stage II patients and the worst OS, CSS and DFS for stage III patients. Furthermore, the macroscopic growth pattern is able to predict the benefits of chemotherapy in stage III patients.
